Progress in clinical follow-up study of dendritic cells combined with cytokine-induced killer for stomach cancer
| Autor: | Cong Chen, Run Wan, Yumin Li, Ruiliang Su, Ling Wang |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
Oncology
medicine.medical_specialty stomach cancer business.industry medicine.medical_treatment dendritic cells combined with cytokine-induced killer Cancer General Medicine Immunotherapy Disease Guideline lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens medicine.disease lcsh:RC254-282 Cytokine Response Evaluation Criteria in Solid Tumors Internal medicine follow-up medicine immunotherapy Stomach cancer business Survival rate |
| Zdroj: | Cancer Translational Medicine, Vol 5, Iss 4, Pp 72-76 (2019) |
| ISSN: | 2395-3977 |
| DOI: | 10.4103/ctm.ctm_32_19 |
| Popis: | Stomach cancer is a common malignant disease and is generally associated with mortality. Immunotherapy, including dendritic cells combined with cytokine-induced killer cells (DC-CIK), poses a significant presence. Follow-up plays a vital role in immunotherapy with stomach cancer by effectively predicting recurrence, promptly diagnosing disease, and early intervening to improve clinical outcome and survival rate. Follow-up guideline takes into these terms which are response evaluation criteria in solid tumors, health-related quality of life, tumor markers, T-lymphocyte subsets, and cytokine on the basis of the National Comprehensive Cancer Network guideline. At the same time, the high-level follow-up team is necessary. Hitherto, there is no specific follow-up guide for immunotherapy. This article reviews the follow-up of DC-CIK with stomach cancer, and it is expected that more researchers focus on this issue to draw up utility guidelines of immunotherapy for stomach cancer. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|